88,99 €
Fourth volume of a classic in the field of organic synthesis, describing retrosynthetic analysis and total synthesis of important molecules
Classics in Total Synthesis IV is a compilation of highly important synthetic methods which lead to complex molecules with valuable properties. From the complex architectures of natural products to the streamlined synthesis of functional molecules, each chapter in Classics in Total Synthesis IV unfolds a unique story. The interplay of mechanisms, reactivity, selectivity, and stereochemical aspects is thoroughly examined, echoing the pedagogical format that has become synonymous with this series. Well-designed graphics are included throughout, and all important parts of the reaction sequences are highlighted.
This volume encapsulates the culmination of new methodologies, emerging trends, and a selection of significant total syntheses undertaken from 2009 to 2022 while additionally including two earlier syntheses from 1979 and 1992 for comparison and to highlight the development of organic synthesis over the past decades. The careful balance between historical context, comments on the molecules’ impact to humankind, and the design and execution aspects of each synthesis creates a narrative that is not only clear but also intellectually stimulating.
Written by K. C. Nicolaou, Ruocheng Yu and Stephan Rigol, Classics in Total Synthesis IV includes 16 chapters covering:
Joining its predecessors in weaving together the threads of scientific discovery, challenge, and intellectual pursuit and establishing strong connections with biology and medicine, Classics in Total Synthesis IV is an essential reference for all future and present synthetic organic chemists.
Sie lesen das E-Book in den Legimi-Apps auf:
Seitenzahl: 1032
Veröffentlichungsjahr: 2024
Cover
Table of Contents
Title Page
Copyright
Foreword
Preface
About the Authors
Abbreviations
1
Introduction: Total Synthesis Marching on with New Methods and Strategies and with Molecules for Biology and Medicine
1.1 Targets
1.2 Methods and Strategies
1.3 Classics in Total Synthesis IV
2
Halichondrin B and Norhalichondrin B
2.1 Introduction
2.2 Kishi’s Retrosynthetic Analysis and Strategy
2.3 Kishi’s Total Syntheses of Halichondrin B and Norhalichondrin B
2.4 Phillips’ Retrosynthetic Analysis and Strategy
2.5 Phillips’ Total Synthesis of Norhalichondrin B
2.6 Nicolaou’s Retrosynthetic Analyses and Strategies
2.7 Nicolaou’s Total Synthesis of Halichondrin B
2.8 Nicolaou’s Total Synthesis of Norhalichondrin B
2.9 … and the Sky’s the Limit
References
3
Daphmanidin E
3.1 Introduction
3.2 Retrosynthetic Analysis and Strategy
3.3 Total Synthesis
3.4 Conclusion
References
4
Epicoccin G and (−)-Acetylaranotin
4.1 Introduction
4.2 Nicolaou’s Retrosynthetic Analysis of Epicoccin G
4.3 Nicolaou’s Total Synthesis of Epicoccin G
4.4 Reisman’s Retrosynthetic Analysis of (−)-Acetylaranotin
4.5 Reisman’s Total Synthesis of (−)-Acetylaranotin
4.6 Tokuyama’s Retrosynthetic Analysis of (−)-Acetylaranotin
4.7 Tokuyama’s Total Synthesis of (−)-Acetylaranotin
4.8 Conclusion
References
5
Taiwaniadducts B, C, and D
5.1 Introduction
5.2 Retrosynthetic Analysis and Strategy
5.3 Total Synthesis
5.4 Conclusion
References
6
Schindilactone A
6.1 Introduction
6.2 Retrosynthetic Analysis and Strategy
6.3 Total Synthesis
6.4 The After Story
References
Note
7
Welwitindolinones
7.1 Introduction
7.2 Rawal’s Retrosynthetic Analysis of Oxidized Welwitindolinones
7.3 Rawal’s Total Synthesis of Oxidized Welwitindolinones
7.4 Garg’s Retrosynthetic Analysis of Oxidized Welwitindolinones
7.5 Garg’s Total Synthesis of Oxidized Welwitindolinones
7.6 Total Syntheses of
N
-Methylwelwitindolinone B Isothiocyanate
7.7 Conclusion
References
8
Ryanodine and Ryanodol
8.1 Introduction
8.2 Deslongchamps’ Retrosynthetic Analysis and Strategy
8.3 Deslongchamps’ Total Synthesis of Ryanodol
8.4 Inoue’s Retrosynthetic Analysis and Strategy
8.5 Inoue’s Total Synthesis of Ryanodol
8.6 Reisman’s Retrosynthetic Analysis and Strategy
8.7 Reisman’s Total Synthesis of Ryanodol
8.8 Inoue’s and Reisman’s Total Syntheses of Ryanodine
8.9 Conclusion
References
9
Gedunin, Mitrephorone A, and Antiretroviral Agent Islatravir
9.1 Introduction
9.2 Renata’s Retrosynthetic Analysis of Gedunin
9.3 Renata’s Chemoenzymatic Synthesis of Gedunin
9.4 Renata’s Retrosynthetic Analysis of Mitrephorone A
9.5 Renata’s Formal Total Synthesis of Mitrephorone A
9.6 Huffman and Fryszkowska’s Retrosynthetic Analysis of Islatravir
9.7 Huffman and Fryszkowska’s Total Synthesis of Islatravir
9.8 Conclusion
References
10
Trioxacarcins
10.1 Introduction
10.2 Myers’ Retrosynthetic Analysis and Strategy
10.3 Myers’ Total Synthesis of Trioxacarcins
10.4 Nicolaou’s Retrosynthetic Analysis and Strategy
10.5 Nicolaou’s Total Synthesis of Trioxacarcins
10.6 Synthesis and Biological Evaluation of Trioxacarcin Analogues
10.7 Conclusion
References
11
Aplyviolene
11.1 Introduction
11.2 Overman’s Retrosynthetic Analysis of Aplyviolene
11.3 Overman’s Total Synthesis of Aplyviolene
11.4 Visible-Light Photoredox Catalysis
11.5 Conclusion
References
12
Dixiamycin B
12.1 Introduction
12.2 Retrosynthetic Analysis and Strategy
12.3 Total Synthesis
12.4 Electroorganic Chemistry
12.5 Conclusion
References
Note
13
Ingenol
13.1 Introduction
13.2 Retrosynthetic Analysis and Strategy
13.3 Total Synthesis
13.4 Synthesis and Biological Evaluation of Ingenol Analogues
13.5 Conclusion
References
14
Cardamom Peroxide, Nodulisporic Acid C, and Bilobalide
14.1 Introduction
14.2 Maimone’s Retrosynthetic Analysis of Cardamom Peroxide
14.3 Maimone’s Total Synthesis of Cardamom Peroxide
14.4 2nd Movement: HAT-Initiated Olefin Hydrogenation and Isomerization
14.5 Shenvi’s Retrosynthetic Analysis of Bilobalide
14.6 Shenvi’s Total Synthesis of Bilobalide
14.7 3rd Movement: HAT-Initiated Olefin Hydrofunctionalizations
14.8 Pronin’s Retrosynthesis Analysis of Nodulisporic Acid C
14.9 Pronin’s Total Synthesis of Nodulisporic Acid C
14.10 To Be Continued…
14.11 Conclusion
References
Notes
15
Batrachotoxin and Conidiogenones
15.1 Introduction
15.2 Snyder’s Retrosynthetic Analysis of Conidiogenones
15.3 Snyder’s Total Synthesis of Conidiogenones
15.4 More Methods and Strategies
15.5 Du Bois’ Retrosynthetic Analysis of Batrachotoxin
15.6 Du Bois’ Total Synthesis of Batrachotoxin
15.7 Conclusion
References
16
Gukulenin B and C—H Functionalization
16.1 Introduction
16.2 Retrosynthetic Analysis and Strategy
16.3 Total Synthesis
16.4 Conclusion
References
Image / Photo Credits
Author Index
Subject Index
End User License Agreement
Chapter 1
Figure 1. Molecular structures of selected natural products featured.
Scheme 1. Representative examples of selected methodologies featured.
Chapter 2
Figure 1. Molecular structures of halichondrins A, B and C (
1
–
3
), norhalicho...
Figure 2. Important stages of the history and development of organochromium ...
Figure 3. (A) Catalytic cycle of the classic Nozaki–Hiyama–Kishi reaction; (...
Figure 4. (A) Catalytic, asymmetric Nozaki–Hiyama–Kishi reaction employing s...
Figure 5. Catalytic cycle of the electrochemical Nozaki–Hiyama–Kishi reactio...
Figure 6. (A) Mechanism of the Achmatowicz rearrangement; (B) mechanism of L...
Figure 7. Kishi’s retrosynthetic analysis of halichondrin B (
2
).
Scheme 1. Synthesis of alkyl bromide fragment
80
.
Scheme 2. Synthesis of vinyl iodide building block
77
.
Scheme 3. Synthesis of aldehyde building block
81
.
Scheme 4. Synthesis of vinyl iodide building block
83
.
Scheme 5. Synthesis of
β
-ketophosphonate building block
122
.
Scheme 6. Synthesis of vinyl iodide building block
82
and its elaboration to...
Scheme 7. Synthesis of advanced macrolactone intermediate
133
.
Scheme 8. Synthesis of advanced aldehyde fragment
137
.
Scheme 9. Final stages and completion of Kishi’s total synthesis of halichon...
Figure 8. Rationale for the formation of halichondrin B (
2
) from cyclization...
Scheme 10. Synthesis of vinyl iodide building block
145
.
Scheme 11. Final stages and completion of Kishi’s total synthesis of norhali...
Figure 9. (A) Molecular structures of eribulin (
149
) and eribulin mesylate (...
Figure 10. Phillips’ retrosynthetic analysis of norhalichondrin B (
5
).
Scheme 12. Synthesis of aldehyde building blocks
81
and
151
.
Scheme 13. Synthesis of vinyl iodide building block
82
.
Scheme 14. Synthesis of allyl alcohol building block
153
.
Scheme 15. Synthesis of advanced intermediate
190
.
Scheme 16. Final stages and completion of Phillips’ total synthesis of norha...
Figure 11. Nicolaou’s retrosynthetic analysis of halichondrin B (
2
).
Figure 12. Nicolaou’s retrosynthetic analysis of norhalichondrin B (
5
).
Scheme 17. Synthesis of tetrahydrofuran ketoaldehyde fragment
195
.
Scheme 18. Synthesis of tricyclic aldehyde fragment
196
.
Scheme 19. Synthesis of
β
-ketophosphonate fragment
197
.
Scheme 20. Synthesis of tricyclic aldehyde ester fragment
198
.
Scheme 21. Synthesis of macrolactonization precursor hydroxy ester
248
.
Scheme 22. Synthesis of macrolactone fragment
250
.
Scheme 23. Final stages and completion of Nicolaou’s total synthesis of hali...
Scheme 24. Synthesis of ketoaldehyde building block
258
.
Scheme 25. Synthesis of octacyclic hydroxy aldehyde C38-
epi
-
199
.
Scheme 26. Final stages and completion of Nicolaou’s total synthesis of norh...
Chapter 3
Figure 1. Molecular structures of selected
daphniphyllum
alkaloids.
Figure 2. Proposed biosynthetic pathways of (A)
proto
-daphniphylline (
14
) an...
Figure 3. Retrosynthetic analysis of (+)-daphmanidin E (
5
).
Scheme 1. (A) Synthesis and resolution of
C
2
-symmetric diketone
23
; (B) dete...
Scheme 2. Synthesis of trisubstituted alkene
35
.
Scheme 3. (A) Synthesis of Claisen rearrangement precursor
41
; (B) synthesis...
Scheme 4. Claisen rearrangements of (A) enol ether
41
and (B) the C10-epimer...
Scheme 5. Second Claisen rearrangement and synthesis of aldehyde
56
.
Scheme 6. Synthesis of primary alkyl iodide
60
.
Scheme 7. (A) Radical cyclization of model compound
61
employing
n
-Bu
3
SnH an...
Figure 4. Proposed mechanism of the cobaloxime
65
-catalyzed alkyl-Heck-type ...
Scheme 8. Synthesis of unsaturated aldehyde
74
via an intramolecular aldol r...
Scheme 9. Completion of the total synthesis of (+)-daphmanidin E (
5
).
Scheme 10. Highlights of Smith’s total synthesis of calyciphylline N (2014)....
Scheme 11. (A–F) Highlights of recent total syntheses of daphenylline.
Scheme 12. (A–D) Highlights of recent total syntheses of himalensine A.
Scheme 13. Highlights of the total syntheses of (A) C5-
epi
-daphlongamine H (...
Scheme 14. (A–D) Highlights of selected total syntheses of other
daphniphyll
...
Chapter 4
Figure 1. Molecular structures of selected epipolythiodiketopiperazines and ...
Scheme 1. Selected early methods for the construction of dihydrooxepine stru...
Scheme 2. Previous methods for diketopiperazine sulfenylation: (A) nucleophi...
Figure 2. Nicolaou’s retrosynthetic analysis of epicoccin G (
3
).
Scheme 3. Nicolaou’s synthesis of bicycle
38
.
Scheme 4. Nicolaou’s synthesis of diketopiperazine
30
.
Scheme 5. (A) Mechanistic rationale for the formation of sulfenylation reage...
Scheme 6. Final stages and completion of Nicolaou’s total syntheses of epico...
Scheme 7. (A) Application of the enolate sulfenylation method to gliotoxin (
Scheme 8. Example of tetrahydrooxepine synthesis via a tungsten vinylidene i...
Figure 3. (A) Reisman’s retrosynthetic analysis of (−)-acetylaranotin (
7
); (...
Scheme 9. Reisman’s synthesis of enantioenriched pyrrolidine
80
.
Scheme 10. Reisman’s synthesis of aldehyde
67
.
Scheme 11. Reisman’s synthesis of chlorotetrahydrooxepine
98
.
Scheme 12. Reisman’s synthesis of diketopiperazine
65
.
Scheme 13. Final stages and completion of Reisman’s synthesis of (−)-acetyla...
Figure 4. Tokuyama’s retrosynthetic analysis of (−)-acetylaranotin (
7
).
Scheme 14. Tokuyama’s synthesis of enone
119
.
Scheme 15. Tokuyama’s synthesis of dihydrooxepine
122
via a Baeyer–Villiger ...
Scheme 16. Final stages and completion of Tokuyama’s synthesis of (−)-acetyl...
Chapter 5
Figure 1. Molecular structures of taiwaniadducts A–E and their putative bios...
Scheme 1. Highlights of Majetich’s biomimetic synthesis of perovskone (
9
).
Figure 2. (A,B) Synthetic challenges and (C) biosynthetic proposal for taiwa...
Scheme 2. Highlights of Johnson’s synthesis of (±)-progesterone (1971).
Scheme 3. Chiral-LBA-based enantioselective polyene cyclization. (A) Yamamot...
Scheme 4. Transition-metal-catalyzed enantioselective polyene cyclization. (...
Scheme 5. Enantioselective polyene cyclization promoted by small organic mol...
Figure 3. Retrosynthetic analysis of taiwaniadducts B–D (
2
,
3
,
4
).
Scheme 6. Syntheses of (A) vinyl iodide
62
and (B) styrene derivative
74
.
Scheme 7. Li’s synthesis of tricyclic intermediate
79
through polyene cycliz...
Scheme 8. Li’s synthesis of taiwaniaquinones A (
6
) and F (
86
) (atom numberin...
Scheme 9. Li’s synthesis of oxatricycle
58
through enantioselective polyene ...
Scheme 10. Li’s synthesis of tricyclic intermediate
97
.
Scheme 11. Li’s synthesis of
trans
-ozic acid (
8
) and its methyl ester
103
.
Scheme 12. (A) Attempted and (B) successful intermolecular Diels–Alder cyclo...
Scheme 13. Final stages and completion of Li’s total synthesis of taiwaniadd...
Figure 4. (A) Proposed biogenesis and (B) synthetic construction of the 6/5/...
Chapter 6
Figure 1. Molecular structures of representative schinortriterpenoids
1
–
7
an...
Scheme 1. Yang and Chen’s synthesis of model bicycle
13
via a Claisen rearra...
Scheme 2. Paquette’s synthesis of model tricycle
21
via a pinacol coupling r...
Scheme 3. Anderson’s synthesis of model tricycle
27
via a cascade of cycliza...
Figure 2. Yang and Chen’s synthetic blueprint for the
AB
ring system of schi...
Figure 3. General reaction equation for the Pauson–Khand reaction.
Figure 4. (A) Currently accepted mechanism for the Co
2
(CO)
8
-mediated Pauson–...
Figure 5. Intramolecular variant of the Pauson–Khand reaction.
Scheme 4. Application of an intramolecular Pauson–Khand reaction in Schreibe...
Scheme 5. Co
2
(CO)
8
/TMTU-catalyzed Pauson–Khand reaction (Yang, Chen
et al
., ...
Figure 6. Pd-mediated carbonylative annulation for the synthesis of
cis
-fuse...
Scheme 6. Application of Pd-catalyzed carbonylative annulation in the total ...
Figure 7. (A) Yang and Chen’s retrosynthetic analysis of the
FGH
ring system...
Figure 8. Yang and Chen’s retrosynthetic analysis of schindilactone A (
1
).
Scheme 7. Importance of templating effect in the construction of eight-membe...
Scheme 8. (A) Racemic and (B) enantioselective versions of the Diels–Alder r...
Scheme 9. Yang, Chen, and Tang’s synthesis of bicyclic bromide
78
.
Scheme 10. Yang, Chen, and Tang’s synthesis of tetracyclic intermediate
76
....
Scheme 11. Yang, Chen, and Tang’s synthesis of pentacyclic intermediate
102
....
Scheme 12. Yang, Chen, and Tang’s synthesis of heptacyclic intermediate
108
....
Scheme 13. Final stages and completion of the Yang/Chen/Tang total synthesis...
Figure 9. Summary of the Yang/Chen/Tang total synthesis of schindilactone A ...
Figure 10. Yang and Chen’s branching-oriented strategy for the divergent tot...
Figure 11. Select schinortriterpenoid natural products succumbed to chemical...
Chapter 7
Figure 1. Molecular structures of representative welwitindolinones
1
–
5
.
Figure 2. Current hypothesis for the biosynthesis of welwitindolinones (part...
Figure 3. Current hypothesis for the biosynthesis of welwitindolinones (part...
Figure 4. Select synthetic approaches toward bicyclo[4.3.1]decane-containing...
Figure 5. Rawal’s retrosynthetic analysis of oxidized welwitindolinones
3a
,
Scheme 1. (A) Catalytic cycle of a typical Pd-catalyzed enolate arylation re...
Scheme 2. Rawal’s model study on the Pd-catalyzed enolate arylation and subs...
Scheme 3. Rawal’s synthesis of vinylogous ester
44
. [The first step followed...
Scheme 4. Rawal’s synthesis of tetracycle
51
.
Scheme 5. Final stages and completion of Rawal’s total synthesis of
N
-methyl...
Scheme 6. Rawal’s collective total synthesis of oxidized welwitindolinones
3
...
Figure 6. (A) First proposal of an aryne intermediate (1902) and a later cha...
Figure 7. Studies on (A) the generation of indolynes, and (B) the nucleophil...
Scheme 7. Overturning the intrinsic regioselectivity in nucleophilic additio...
Figure 8. Garg’s retrosynthetic analysis of oxidized welwitindolinones
3a
,
3
...
Scheme 8. Garg’s synthesis of tetracycle
103
through an intramolecular indol...
Scheme 9. Failed substrates for the intramolecular indolyne cyclization. (A)...
Scheme 10. Garg’s synthesis of oxindole intermediate
117
.
Scheme 11. Garg’s synthesis of bridgehead amine
123
via intramolecular C—H a...
Scheme 12. Final stages and completion of Garg’s total synthesis of oxidized...
Figure 9. Failed attempts to install the C13
α
-chloride functionality....
Scheme 13. Garg’s total synthesis of
N
-methylwelwitindolinone B isothiocyana...
Scheme 14. Rawal’s total synthesis of
N
-methylwelwitindolinone B isothiocyan...
Chapter 8
Scheme 1. (A) Molecular structures of ryanodine (
1
), ryanodol (
2
), and relat...
Figure 1. Semisynthetic [
3
H]-labeled ryanodine analogues.
Figure 2. Schematic representation of a striated muscle cell.
Figure 3. Deslongchamps’ retrosynthetic analysis of ryanodol (
2
).
Scheme 2. Deslongchamps’ synthesis of dienone
26
.
Scheme 3. (A) Deslongchamps’ model study of the Diels–Alder reaction; (B) ad...
Scheme 4. Deslongchamps’ synthesis of dienophile (
S
)-
40
and its conversion t...
Scheme 5. (A) Deslongchamps’ synthesis of aldol products
53
and
55
; (B) dias...
Scheme 6. Study on the reactions between acetals
59a,b
and ozone.
Scheme 7. Deslongchamps’ synthesis of intermediate
68
via
C
-ring decoration ...
Scheme 8. Deslongchamps’ synthesis of anhydroryanodol (
4
).
Scheme 9. Final stages and completion of Deslongchamps’ total synthesis of (...
Figure 4. Inoue’s retrosynthetic analysis of ryanodol (
2
).
Scheme 10. (A) Inoue’s synthesis of
C
2
-symmetric diketone (+)-
84
; (B) Song a...
Scheme 11. Inoue’s synthesis of
C
2
-symmetric diketone
82
.
Scheme 12. (A) Inoue’s proposed desymmetrization of diketone
82
; (B) success...
Scheme 13. Inoue’s synthesis of intermediate
111
via bridgehead radical
110
....
Scheme 14. Inoue’s synthesis of advanced intermediate
116
via
C
-ring formati...
Scheme 15. Final stages and completion of Inoue’s total synthesis of (+)-rya...
Figure 5. Reisman’s retrosynthetic analysis of ryanodol (
2
).
Scheme 16. (A) Reisman’s exploratory hydroxylation studies; (B) a one-pot do...
Scheme 17. Reisman’s synthesis of tetracycle 122 using an intramolecular Pau...
Scheme 18. Reisman’s synthesis of enone
142
via
A
-ring oxidation/functionali...
Scheme 19. Final stages and completion of Reisman’s total synthesis of (+)-r...
Scheme 20. Deslongchamps’ and Inoue’s initial acylation studies.
Scheme 21. Inoue’s total synthesis of (+)-ryanodine (
1
).
Scheme 22. Reisman’s synthesis of (+)-anhydroryanodine (
3
).
Scheme 23. Reisman’s synthesis of (+)-ryanodine (
1
).
Scheme 24. Comparison of the orders of ring formation in the three syntheses...
Chapter 9
Figure 1. Symbolic illustrations demonstrating Fischer’s lock and key model ...
Figure 2. Historic milestone achievements toward chiral resolution: (A) manu...
Figure 3. (A) Structure of the enzyme commission (EC) number for the classif...
Figure 4. Schematic overview over the individual steps of the iterative cycl...
Figure 5. Requirement (left) and general course (right) of directed evolutio...
Figure 6. Renata’s retrosynthetic analysis of gedunin (
26
).
Scheme 1. Synthesis of alkyl iodide lactone
32
.
Scheme 2. Synthesis of bicyclic hydroxy ketone
33
.
Scheme 3. Final stages and completion of Renata’s synthesis of gedunin (
26
)....
Figure 7. Renata’s retrosynthetic analysis of mitrephorone A (
27
).
Scheme 4. Synthesis of
ent
-trachylobane carboxylic acid fragment
50
.
Scheme 5. Final stages and completion of Renata’s formal total synthesis of ...
Figure 8. Huffman and Fryszkowska’s retrosynthetic analysis of islatravir (
3
...
Scheme 6. Huffman and Fryszkowska’s chemoenzymatic total synthesis of islatr...
Chapter 10
Figure 1. Molecular structures of representative trioxacarcins
1
–
8
and their...
Figure 2. Preparation and characterization of DNA–trioxacarcin A complex
10
...
Figure 3. Representation of a partial X-ray crystallographic structure of DN...
Scheme 1. Structural specificity in the binding of trioxacarcin A (
3
) with D...
Figure 4. Tang’s proposed biosynthesis of trioxacarcins (2015).
Scheme 2. Hauser’s and Kraus’ original reports on the annulation reactions b...
Figure 5. (A) Mechanism and (B,C) selected substrate scopes of the Hauser–Kr...
Scheme 3. Switch of strategy from Hauser–Kraus annulation to Diels–Alder rea...
Scheme 4. Hauser–Kraus annulations in Nicolaou’s (A) first-generation, and (...
Figure 6. Myers’ retrosynthetic analysis of DC-45-A2 (
1
), DC-45-A1 (
2
), and ...
Scheme 5. Myers’ synthesis of cyanophthalide
76
.
Scheme 6. Myers’ synthesis of cyclohexenone derivative
77
via a diastereosel...
Scheme 7. (A) Baylis–Hillman reaction generating dioxane product
95
; (B) its...
Scheme 8. Myers’ synthesis of diazo compound
75
.
Scheme 9. Fragment coupling and completion of Myers’ total synthesis of DC-4...
Scheme 10. Myers’ synthesis of trioxacarcinoside A glycosyl donors
109
and
1
...
Scheme 11. (A) Final stages and completion of Myers’ total synthesis of DC-4...
Scheme 12. Myers’ synthesis of trioxacarcinose B bis-acetate (
120
).
Scheme 13. Final stages and completion of Myers’ total synthesis of trioxaca...
Figure 7. Naturally occurring trioxacarcins synthesized in the Nicolaou grou...
Figure 8. Nicolaou’s retrosynthetic analysis of advanced intermediate
71
.
Scheme 14. Nicolaou’s synthesis of tricyclic intermediate
138
.
Scheme 15. Nicolaou’s synthesis of intermediate
147
via sequential functiona...
Scheme 16. Nicolaou’s synthesis of epoxyketone
154
.
Scheme 17. Lewis acid-induced stereodivergent rearrangement of epoxyketone
1
...
Scheme 18. Final stages and completion of Nicolaou’s total synthesis of DC-4...
Scheme 19. Nicolaou’s synthesis of glycosyl donors
162
and
163
.
Scheme 20. Nicolaou’s synthesis of glycosyl donors
166
,
167a
, and
167b
.
Scheme 21. Final stages and completion of Nicolaou’s total synthesis of trio...
Scheme 22. Nicolaou’s total synthesis and full structural elucidation of tri...
Scheme 23. (A) Nicolaou’s syntheses of designed analogues
183
and
191
; (B) c...
Scheme 24. Myers’ synthesis and biological evaluation of iso-DC-45-A2 (
192
)....
Scheme 25. (A) Myers’ synthesis of antibody–drug conjugate
198
; (B) proposed...
Chapter 11
Figure 1. Biosynthetic hypothesis for aplyviolene (
1
) and the related natura...
Figure 2. (A) Feasibility interrogation of the assembly of the bis-acetal un...
Scheme 1. Overman’s synthesis of silyl enol ether
24
.
Scheme 2. Final stages and completion of Overman’s first-generation synthesi...
Scheme 3. Overman’s synthesis of enone intermediate
33
(the first two steps ...
Scheme 4. Overman’s studies on the preparation and conjugate addition of org...
Figure 3. Potential precursors of a
cis
-perhydroazulene coupling partner bea...
Figure 4. Electronic configurations of the ground,
1
MLCT and
3
MLCT states of...
Scheme 5. (A) Photocatalytic reduction of phenacyl bromide (
50
) to acetophen...
Scheme 6. (A) Okada and Oda’s radical conjugate addition enabled by visible-...
Scheme 7. Overman’s streamlined synthesis of aplyviolene (
1
) featuring a pho...
Scheme 8. Examples of photochemical [2+2] cycloadditions.
Scheme 9. (A) Stephenson’s dehalogenation reaction enabled by visible-light ...
Scheme 10. Selected total syntheses featuring radical addition reactions ena...
Scheme 11. (A) Visible-light-driven [2+2] cycloaddition of bis-enones; (B) r...
Scheme 12. Visible-light-driven [4+2] cycloaddition in the total synthesis o...
Scheme 13. Photochemical functionalizations of alkenes and electron-rich are...
Scheme 14. (A) Asymmetric
α
-alkylation of aldehydes via cooperative vis...
Scheme 15. Visible-light photoredox catalysis merged with HAT catalysis [(A)...
Scheme 16. Room temperature C—H arylation enabled by visible-light metallaph...
Scheme 17. Merging visible-light photoredox catalysis with nickel catalysis ...
Figure 5. Comparison of the ground and excited state electronic configuratio...
Scheme 18. Photoinduced, copper-catalyzed enantioconvergent C—N coupling (Fu...
Scheme 19. An example of near-infrared (NIR)-light photoredox catalysis (Cam...
Chapter 12
Figure 1. Molecular structures of representative oligomeric indole alkaloids...
Scheme 1. (A) Current understanding of the biosynthesis of ditryptophenaline...
Scheme 2. (A) Retrosynthetic analysis of communesin F (
18
); (B) Movassaghi’s...
Figure 2. (A) Li’s rationale on the biosynthesis of naseseazine B (
2
); (B) t...
Scheme 3. Different strategies toward the C5—C5′ linkage construction in the...
Scheme 4. Baran’s synthesis of (±)-psychotrimine [(±)-
5
] featuring the const...
Figure 3. Oligomeric indole alkaloids with N—N linkages.
Figure 4. Baran’s retrosynthetic analysis of dixiamycin A/B (
49a/b
).
Scheme 5. Baran’s synthesis of diene fragment
55
(the first five steps follo...
Scheme 6. Baran’s synthesis of xiamycin A (
50
).
Figure 5. Cyclic voltammetry of adsorbed (A) and dissolved (B) analyte: sche...
Figure 6. Cyclic voltammogram of carbazole (
64
) and chemical interpretation ...
Scheme 7. Baran’s electrochemical oxidative dimerization of (A) carbazole (
6
...
Scheme 8. Reaction course and synthetic applications of Kolbe and non-Kolbe ...
Scheme 9. Shono oxidation and the “cation pool” method.
Scheme 10. Comparison of electrochemical and PhI(OAc)
2
-mediated oxidative ma...
Scheme 11. TEMPO-mediated electrochemical oxidation of alcohols (Semmelhack
Scheme 12. Mediated electrochemical oxidation of C—H bonds (Baran
et al
., 20...
Scheme 13. Pd-Catalyzed electrochemical C—H acetoxylation (Mei
et al
., 2017)...
Scheme 14. Mn-catalyzed electrochemical olefin difunctionalization reactions...
Scheme 15. Electrophotocatalysis for the generation of extremely strong oxid...
Chapter 13
Figure 1.
In
,
out
-bridgehead stereochemistry and its embodiment in the struct...
Scheme 1. Synthesis of model tricycle
10
via a de Mayo-type [2+2] cycloaddit...
Scheme 2. Winkler’s total synthesis of (±)-ingenol [(±)-
4
] (2002).
Scheme 3. Tanino and Kuwajima’s total synthesis of (±)-ingenol [(±)-
4
] (2003...
Scheme 4. Wood’s total synthesis of (−)-ingenol [(−)-
4
] (2004).
Scheme 5. Improved isolation protocol of ingenol (
4
) and its semisynthetic c...
Figure 2. Biosynthetic pathway of jolkinol C (
54
), a possible key intermedia...
Figure 3. (A) Mapping isoprene units onto the skeletons of jolkinol C and in...
Figure 4. Baran’s retrosynthetic analysis of (−)-ingenol [(−)-
4
].
Scheme 6. Baran’s synthesis of aldehyde (
R
)-
66
(the first three steps follow...
Scheme 7. Baran’s synthesis of methyl-ketone building block
65
.
Scheme 8. Baran’s synthesis of tetracycle
62
via fragment coupling and an al...
Scheme 9. Failed attempts to perform a vinylogous pinacol rearrangement on a...
Scheme 10. Baran’s synthesis of carbonate intermediate
82
.
Scheme 11. (A) Successful vinylogous pinacol rearrangement of carbonate subs...
Scheme 12. Undesired retro-pinacol pathways from intermediate
85
.
Scheme 13. Final stages and completion of Baran’s total synthesis of (−)-ing...
Figure 5. Comparison of two synthetic routes from ethyl-arene
96
to diol
97
...
Figure 6. Summary of Baran’s two-phase redox-economic total synthesis of ing...
Figure 7. Synthesis and biological evaluation of diversely oxygenated ingeno...
Chapter 14
Scheme 1. (A) Co-catalyzed Markovnikov hydration of unactivated olefins (Muk...
Figure 1. Currently accepted mechanism of the Mukaiyama hydration and relate...
Scheme 2. Nojima’s study of the Co-catalyzed hydrosilylperoxidation reaction...
Figure 2. (A) Representative endoperoxide natural products with antimalarial...
Scheme 3. Maimone’s synthesis of key intermediate
31
.
Scheme 4. Study and optimization of the radical peroxidation cascade leading...
Figure 3. Summary of Maimone’s four-step total synthesis of cardamom peroxid...
Scheme 5. (A) Mn-catalyzed hydrogenation of electron-neutral olefins with th...
Scheme 6. Selective reduction of C=C bonds in the presence of other competin...
Scheme 7. Co-catalyzed isomerization of terminal alkenes (Shenvi
et al
., 201...
Scheme 8. Application of HAT hydrogenation in Zhang’s total synthesis of apl...
Figure 4. Molecular structures of ginkgolide B (
69
) and bilobalide (
70
).
Figure 5. Prior total syntheses of bilobalide by Corey
et al
. (1987, 1988) a...
Figure 6. Shenvi’s retrosynthetic analysis of bilobalide (
70
).
Scheme 9. Shenvi’s synthesis of cyclopentene intermediate
79
.
Scheme 10. (A) Diastereoselective Mukaiyama-type hydration of olefin
79
; (B)...
Scheme 11. (A) Failed attempts toward diastereoselective bond formation at C...
Scheme 12. Advancement of alkyne intermediate
95
to bilobalide (
70
).
Scheme 13. Hydroxylation of intermediate
77
at the undesired C1 position.
Scheme 14. Successful and reproducible C10-hydroxylation to provide bilobali...
Figure 7. Co- or Mn-catalyzed olefin hydrofunctionalizations (Carreira
et al
Scheme 15. Boger’s synthesis of vinblastine (
120
) and analogues thereof usin...
Scheme 16. Baran’s olefin hydroamination with nitroarenes (2015).
Figure 8. Baran’s HAT-initiated olefin cross-coupling (2014, 2017).
Figure 9. Molecular structures of nodulisporic acids A–F (
136
–
141
) and Smith...
Figure 10. Pronin’s retrosynthetic analysis of nodulisporic acid C (
138
).
Scheme 17. Pronin’s first-generation synthesis of tricyclic fragment
150
.
Scheme 18. Pronin’s second-generation synthesis of tricyclic fragment
150
an...
Scheme 19. Pronin’s synthesis of aryl chloride fragment
145
.
Scheme 20. Final stages and completion of Pronin’s total synthesis of noduli...
Figure 11. Co-catalyzed asymmetric olefin hydrofunctionalization (Pronin
et
...
Figure 12. Co/Ni-dual catalyzed olefin hydroarylation (Shenvi
et al
., 2016, ...
Figure 13. Biosynthetic machineries which likely provided inspiration for th...
Chapter 15
Scheme 1. Construction of an all-carbon quaternary stereocenter via asymmetr...
Scheme 2. (A) Possible biosynthetic pathway of a family of nonclassical taxa...
Scheme 3. Application of Claisen rearrangement for the construction of an al...
Scheme 4. Examples of transition metal-catalyzed allylic substitution reacti...
Scheme 5. Examples of transition metal-catalyzed conjugate addition reaction...
Scheme 6. Application of asymmetric intramolecular Heck reaction in Overman’...
Figure 1. Snyder’s retrosynthetic analysis of conidiogenone (
52
) and its sib...
Scheme 7. Snyder’s synthesis of bicyclic ketone
60
.
Scheme 8. Snyder’s attempted synthesis of intermediate
73
.
Scheme 9. Snyder’s synthesis of tricyclic iodide
56
via a modified intramole...
Figure 2. Currently understood mechanism of the Cr/Co-catalyzed NHK-type rea...
Scheme 10. Comparison of the performances of substrates
56
and C1-
epi
-
56
in ...
Scheme 11. Final stages and completion of Snyder’s synthesis of conidiogenon...
Scheme 12. (A) Failed and (B) successful endeavours for casting the C5 all-c...
Scheme 13. Enantioselective pinacol rearrangement for the construction of al...
Scheme 14. Total synthesis of (
S
)-sporochnol (
116
) via successive rearrangem...
Scheme 15. Total synthesis of (±)-herbertenolide [(±)-
117
] via photolytic ge...
Figure 3. Construction of all-carbon quaternary stereocenter(s) via addition...
Figure 4. Molecular structures of batrachotoxin (
130
) and its parent alcohol...
Scheme 16. Highlights of Kishi’s total synthesis of (±)-batrachotoxinin A [(...
Figure 5. Du Bois’ retrosynthetic analysis of batrachotoxin (
130
) and batrac...
Scheme 17. Du Bois’ synthesis of methylene-cyclopentanone fragment
141
(the ...
Scheme 18. Du Bois’ synthesis of terminal alkyne intermediate
139
.
Figure 6. Du Bois’ preliminary explorations of the radical cyclization.
Scheme 19. (A) Failed and (B) successful endeavours from the Du Bois team fo...
Scheme 20. Du Bois’ synthesis of hexacyclic lactam
173
.
Scheme 21. Du Bois’ synthesis of advanced intermediate
137
.
Scheme 22. Final stages and completion of Du Bois’ total synthesis of batrac...
Chapter 16
Scheme 1. C(sp
2
)—H functionalization via electrophilic aromatic substitution...
Scheme 2. C(sp
2
)—H functionalization via nucleophilic aromatic substitution ...
Scheme 3. C4-selective functionalization of pyridine derivatives (McNally
et
...
Scheme 4. Minisci-type reactions: (A) initial discovery by Minisci
et al
. (1...
Scheme 5. Siegel’s radical-mediated C(sp
2
)—H oxidation (2013).
Scheme 6. (A) Knochel’s regiodivergent C—H deprotonation/functionalization (...
Scheme 7. C—H activation mediated by stoichiometric amounts of Pd(OAc)
2
(Rya...
Scheme 8. Sanford’s Pd-catalyzed C—H acetoxylation directed by (A) a 2-pyrid...
Scheme 9. Application of C—H oxidation reactions in the total syntheses of (...
Scheme 10. Yu’s Pd-catalyzed C—H methylation directed by a carboxylate group...
Scheme 11. (A,B) Acceleration effects of MPAA ligands on Pd-catalyzed direct...
Scheme 12. Application of ligand-accelerated C—H olefination in the total sy...
Scheme 13. Desymmetrization of achiral aromatic compounds via (A) enantiosel...
Scheme 14. Applications of Pd-catalyzed asymmetric C—H functionalizations in...
Scheme 15. (A) The Catellani reaction and its proposed mechanism; (B) applic...
Scheme 16. Adaptations of the Catellani reaction for
meta
-C—H functionalizat...
Scheme 17. Pd-catalyzed directed functionalizations of (A)
meta
-C—H bonds (Y...
Scheme 18. Examples of Rh-catalyzed aromatic C—H functionalization [(A) Cram...
Scheme 19. Ir-catalyzed C—H borylation of (hetero)aromatic compounds [(A) Sm...
Scheme 20. Effect of ligand structure on the regiochemical outcome of Ir-cat...
Scheme 21. Aromatic C—H functionalization via formal carbene/nitrene inserti...
Figure 1. Site-selective C—H functionalization of quinoline—a case study.
Scheme 22. (A) Sanford’s directed C(sp
3
)—H acetoxylation and (B,C) its appli...
Scheme 23. Dong’s oxime-directed C(sp
3
)—H acetoxylation (2012).
Scheme 24. (A) Auxiliary-assisted arylation of secondary C—H bonds (Daugulis...
Scheme 25. (A) Yu’s ligand-enabled secondary C—H arylation (2012) and (B) it...
Scheme 26. C(sp
3
)—H functionalization via “nonstandard” palladacycle interme...
Scheme 27.
γ
-Selective C—H functionalization via the participation of a...
Scheme 28. Hydroxy group-directed Ir-catalyzed functionalization of (A) prim...
Scheme 29. Ir-catalyzed nondirected C—H functionalization on saturated heter...
Figure 2. Two common mechanisms for C(sp
3
)—H insertion by an [M]=X complex (...
Figure 3. Intramolecular and intermolecular C—H insertions of metal carbenoi...
Scheme 30. Rh-catalyzed site-selective C—H carbene insertions (Davies
et al
....
Scheme 31. Macrocycle formation via C—H carbene insertion (Davies
et al
., 20...
Scheme 32. Examples of Rh-catalyzed intermolecular C—H amination (Du Bois
et
...
Scheme 33. Examples of Fe-catalyzed intermolecular C—H amination (Che
et al
....
Scheme 34. Fe-catalyzed oxidation of unactivated tertiary C—H bonds (White
e
...
Scheme 35. (A) Catalyst-governed site-selective oxidation of secondary C—H b...
Scheme 36. C—H functionalization of ethane and methane mediated by a polyoxo...
Scheme 37. C(sp
3
)—H functionalization mediated by oxygen radicals. [(A) Bart...
Scheme 38. C(sp
3
)—H functionalization via (A) classical and (B) modified Hof...
Scheme 39. Intermolecular amidylradical-mediated C(sp
3
)—H functionalization ...
Figure 4. Tabulated summary of aromatic and aliphatic C—H functionalizations...
Figure 5. Molecular structures of gukulenins B (
290
) and A (
291
) and their s...
Figure 6. Molecular structures of tropolone (
292
), its methyl ether (
294
), a...
Scheme 40. Formulation of a “sequential tropolone functionalizations” strate...
Figure 7. Nicolaou’s forward synthetic plan toward gukulenin B (
290
).
Scheme 41. Nicolaou’s synthesis of tropolone intermediate
309
.
Scheme 42. Nicolaou’s synthesis of intermediate
326
through successive olefi...
Scheme 43. Nicolaou’s regio- and atroposelective functionalization of the tr...
Scheme 44. Nicolaou’s synthesis of the right-hand fragment
338
via Ir-cataly...
Scheme 45. Nicolaou’s synthesis of tricycle
342
via S
E
Ar-type C
γ
—H func...
Scheme 46. (A,B) Failed attempts toward the synthesis of an
α
,
β
,
γ
...
Scheme 47. Nicolaou’s synthesis of the left-hand monomeric fragment
351
via ...
Scheme 48. Nicolaou’s synthesis of pseudodimer
355
via two consecutive cross...
Scheme 49. Final stages and completion of Nicolaou’s total synthesis of guku...
Figure 8. Speculated biosynthesis of gukulenin B (
290
).
Cover
Table of Contents
Title Page
Copyright
Foreword
Preface
About the Authors
Abbreviations
Begin Reading
Image / Photo Credits
Author Index
Subject Index
End User License Agreement
ii
iii
iv
v
vi
vii
viii
ix
x
xi
xii
xiii
xiv
xxiv
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
440
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
Nicolaou, K. C. / Sorensen, E. J.
Classics in Total Synthesis – Targets, Strategies, Methods
1996
ISBN 978-3-527-29231-8 (Softcover)
Nicolaou, K. C. / Snyder, S. A.
Classics in Total Synthesis II – More Targets, Strategies, Methods
2003
ISBN 978-3-527-30684-8 (Softcover)
Nicolaou, K. C. / Chen, J. S.
Classics in Total Synthesis III – Further Targets, Strategies, Methods
2011
ISBN 978-3-527-32958-8 (Hardcover)
ISBN 978-3-527-32957-1 (Softcover)
Carreira, E. M. / Kvaerno, L.
Classics in Stereoselective Synthesis
2009
ISBN 978-3-527-32452-1 (Hardcover)
ISBN 978-3-527-29966-9 (Softcover)
Corey, E. J. / Cheng, X.-M.
The Logic of Chemical Synthesis
1995
ISBN 978-0-471-11594-6 (Softcover)
Corey, E. J. / Wu, Y.-J.
Molecules Engineered Against Oncogenic Proteins and Cancer
2023
ISBN 978-1-394-20708-4 (Hardcover)
K. C. Nicolaou
Ruocheng Yu
Stephan Rigol
With a Foreword by
E. J. Corey
Authors
Prof. Dr. K. C. NicolaouRice University6100 Main StreetHouston, TX 77005USA
Dr. Ruocheng YuRice University6100 Main StreetHouston, TX 77005USA
Dr. Stephan RigolRice University6100 Main StreetHouston, TX 77005USA
Cover Design: Wiley
Cover Image: © Black sponge Halichondria okadai, Courtesy of Dr. Norihito Maru
All books published by WILEY-VCH are carefully produced. Nevertheless, authors, editors, and publisher do not warrant the information contained in these books, including this book, to be free of errors. Readers are advised to keep in mind that statements, data, illustrations, procedural details or other items may inadvertently be inaccurate.
Library of Congress Card No.Applied for
British Library Cataloguing-in-Publication DataA catalogue record for this book is available from the British Library.
Bibliographic information published by the Deutsche NationalbibliothekThe Deutsche Nationalbibliothek lists this publication in the Deutsche Nationalbibliografie; detailed bibliographic data are available on the Internet at http://dnb.d-nb.de.
© 2025 WILEY-VCH GmbH, Boschstraße 12, 69469 Weinheim, Germany
All rights reserved (including those of translation into other languages, text and data mining and training of artificial technologies or similar technologies). No part of this book may be reproduced in any form – by photoprinting, microfilm, or any other means – nor transmitted or translated into a machine language without written permission from the publishers. Registered names, trademarks, etc. used in this book, even when not specifically marked as such, are not to be considered unprotected by law.
Print ISBN: 978-3-527-34877-0ePDF ISBN: 978-3-527-83148-7ePub ISBN: 978-3-527-83149-4
It is both an honor and a pleasure to pen the foreword for the fourth volume of Classics in Total Synthesis, as I did for the three previous volumes. This series has emerged as a guiding light in the ever-expansive realm of total synthesis. As we embark on this intellectual journey, it is essential to reflect on the profound impact that the preceding volumes have had on our understanding of the total synthesis of complex molecules.
Classics IV seamlessly joins its predecessors, weaving together the threads of scientific discovery, challenge, and intellectual pursuit. This series has proven to be not only a chronicle of synthetic triumphs but also a celebration of the inherent complexity and beauty, which are inherent to total synthesis endeavours.
As I delve into the prepublication draft of this volume, I find the presented synthetic research remarkably clear and vivid and find each of the chapters exerting a captive force. The collection of synthetic triumphs within these pages invites readers to traverse the great complexity and variety that is characteristic for total synthesis journeys. The challenges presented verge on the impossible, demanding not only mental and practical rigor but also unwavering dedication, persistence, and hard work.
One of the remarkable aspects of the Classics in Total Synthesis series has been its ability to transcend disciplinary boundaries. While rooted in chemistry, the series establishes strong connections with biology and medicine. This interdisciplinary approach highlights the relevance of synthetic chemistry at a fundamental level to human well-being, health, and education.
The educational approach employed by the authors is enormously valuable and effective. The careful balance between historical context, comments on the molecules’ impact to humankind, and the design and execution aspects of each synthesis creates a narrative that is not only clear but also intellectually stimulating. It is a sheer delight to revisit each synthetic success guided by the insightful analyses found throughout Classics IV.
As mentioned in the Forewords of the earlier volumes, the enormous number of achievements in total synthesis is so large that capturing them all in a single collection is an impossible task. However, Classics in Total Synthesis has risen to this challenge with grace, presenting a carefully made selection that not only represents outstanding achievements, namely the construction of highly complex natural products, but also covers a diverse set of synthetic methodologies.
The question arises: Have we reached a plateau in scientific or intellectual discovery within the field of synthetic organic chemistry? The answer, as echoed by the authors, is a resounding no. The opportunities for new developments and discoveries are as vast as the synthetic targets that remain to be uncovered, chased, and conquered. Today’s total synthesis is not a culmination but a prelude to a future that promises continued dynamic development, relentlessly pushing the boundaries of what we perceive as possible.
In crafting this Foreword, I thank K. C. Nicolaou, Ruocheng Yu, and Stephan Rigol for their work in sustaining the heritage of Classics in Total Synthesis. May the publication of Classics IV be met with the same enthusiasm and admiration as it was rightly the case with its predecessors. I am confident that studying the Classics will empower upcoming generations of chemists, fostering a profound comprehension and appreciation for the significance of total synthesis. This endeavour will instill in them a deep understanding of the value and importance of natural products through showcasing the appealing beauty inherent to their molecular architectures and such insights will serve as catalyst, inspiring these aspiring chemists to embark on their own transformative journeys of exploration, discovery, and innovation.
E. J. CoreyHarvard University23 January 2024
As we embark on the journey into the pages of this fourth volume in the Classics in Total Synthesis series, we find ourselves standing at the precipice of a new chapter in the evolving narrative of organic synthesis. This series, conceived with the dual purpose of documenting historical milestones and serving as an educational beacon, has traversed through the annals of synthetic chemistry, illuminating the paths carved by the practitioners of our field.
In the preceding volumes (Classics I, Classics II, and Classics III), we witnessed the meticulous unraveling of nature’s complexity through ingenious synthetic strategies. Classics I laid the groundwork, introducing us to the profound philosophy and purpose of total synthesis. Building upon these foundational principles, Classics II expanded our horizons with a focused exploration of the transformative potential that the 21st century holds for synthetic chemistry. Classics III brought us up to speed with the rapid advancements of the recent era, showcasing the elegance, brevity, and environmental consciousness that characterize the latest synthetic frontiers.
As we delve into the rich tapestry of Classics IV, our aim remains steadfast—to chronicle the evolving landscape of total synthesis. This volume encapsulates the culmination of new methodologies, emerging trends, and a selection of significant total syntheses undertaken from 2009 to 2022 while additionally including two earlier syntheses from 1979 and 1992 for comparison and to highlight the development of organic synthesis over the past decades. In the spirit of its predecessors, Classics IV seeks to inspire and educate, weaving together the historical context, the intricacies of retrosynthetic analysis, and the tactical brilliance in execution.
From the complex architectures of natural products to the streamlined synthesis of functional molecules, each Chapter in Classics IV unfolds a unique story. The interplay of mechanisms, reactivity, selectivity, and stereochemical aspects is thoroughly examined, echoing the pedagogical format that has become synonymous with this series. Clear Schemes and Figures accompany the text, providing a visual guide to the sophisticated dance of atoms that is initiated by organic chemists, breaking bonds between some of them and forming new ones between others to build the molecules of Nature and their designed analogues in the laboratory.
The creation of Classics IV has been a collaborative endeavour, made possible by the dedication and insights of numerous individuals. Besides all scientists involved in the presented synthetic journeys, we extend our deepest gratitude to Janise L. Petrey for her careful editing, ensuring a seamless reading experience and bringing clarity to complex concepts; Jenna L. Kripal for her valuable assistance in creating stimulating and engaging frontispieces for each Chapter; and the Editorial staff from Wiley-VCH for their professional and straightforward handling of our manuscript and its translation to the finished book that you are holding in your hands now.
We dedicate Classics IV to the continued legacy of organic synthesis and recognize the responsibility that lies ahead. To the students, researchers, and practitioners who hold these pages, we impart the torch of innovation and the quest for knowledge. May this volume inspire the next generation of synthetic organic chemists, just as its predecessors have done, to further sharpen the art and science of organic synthesis in general and total synthesis in particular for the betterment of humankind.
Houston, TXSeptember 2024
K. C. NicolaouRuocheng YuStephan Rigol
K. C. Nicolaou was born in Cyprus and educated in the United Kingdom and United States. He currently holds the Harry C. and Olga K. Wiess Chair in Natural Sciences at Rice University. His previous appointments include positions at the University of Pennsylvania and joint positions as the Darlene Shiley Chair in Chemistry and the Aline W. and L. S. Skaggs Chair in Chemical Biology at The Scripps Research Institute and as Distinguished Professor of Chemistry at the University of California, San Diego. The impact of his work in chemistry, biology, and medicine flows from his contributions to chemical synthesis as described in over 800 publications. He is the recipient of numerous Prizes, Awards, and Honors (e.g., Nemitsas Prize, Wolf Prize, and the Robert Koch Gold Medal) and has been elected to several Academies, such as the New York Academy of Sciences; the American Academy of Arts and Sciences; the American Philosophical Society; the Royal Society of London; the National Academy of Sciences (USA); the Royal Society of Chemistry (UK); the Cyprus Academy of Sciences, Letters and Arts; and the German Academy of Sciences Leopoldina.
Ruocheng Yu studied chemistry at Peking University, China, as an undergraduate student under the supervision of Zhen Yang and Jiahua Chen. After receiving his bachelor’s degree in 2012, he went on to pursue his doctoral studies under the guidance of K. C. Nicolaou at The Scripps Research Institute and later Rice University. In the Nicolaou lab, he completed the total syntheses of several natural and designed molecules, including gukulenin B. He is currently a postdoctoral fellow in the laboratory of Emily Balskus.
Stephan Rigol received his higher education at Leipzig University, Germany, where he obtained his undergraduate degrees, and received his doctorate in 2013 after carrying out research in the fields of synthetic organic and medicinal chemistry under the guidance of Athanassios Giannis. He then moved to the United States to join the group of K. C. Nicolaou at Rice University where he is currently conducting research in the field of natural products chemistry with a particular focus on molecules with antibacterial and anticancer activities.
18-crown-6
1,4,7,10,13,16-hexaoxacyclooctadecane
4CzIPN
1,2,3,5-tetrakis(carbazol-9-yl)-4,6-dicyanobenzene
9-BBN
9-borabicyclo[3.3.1]nonane
A
adenine
Ac
acetyl
acac
acetoacetate
Ad
adamantane
AD
asymmetric dihydroxylation
ADC
antibody–drug conjugate
ADP
adenosine diphosphate
AIBN
2,2′-azobisisobutyronitrile
AIDS
acquired immunodeficiency syndrome
α
KG
α
-ketoglutaric acid disodium salt dihydrate
AK
actinic keratosis
Alloc
allyloxycarbonyl
amphos
di-
tert
-butyl(4-dimethylaminophenyl)phosphine
aq.
aqueous
AQN
anthraquinone
ar
or
Ar
aryl
ATP
adenosine triphosphate
ATCC
American Type Culture Collection
ax
axial
AZADO
2-azaadamantane-
N
-oxyl
BAIB
bis(acetoxy)iodobenzene
BAr
F
tetrakis[3,5-bis(trifluoromethyl)-phenyl]borate
BDE
bond dissociation energy
BHT
2,6-di-
tert
-butyl-4-methylphenol
BINAP
([1,1′-binaphthalene]-2,2′-diyl)bis-(diphenylphosphane)
BINOL
2,2′-dihydroxy-1,1′-binaphthyl
BIPHEP
2,2′-bis(diphenylphosphino)-1,1′-biphenyl
Bn
benzyl
BNAH
1-benzyl-1,4-dihydronicotinamide
Boc
tert
-butoxycarbonyl
BOM
benzyloxymethyl
BOP
bis(2-oxo-3-oxazolidinyl)phosphinic
bpy
2,2′-bipyridine
bpz
2,2′-bipyrazine
brsm
based on recovered starting material
Bu
butyl
Bz
benzoyl
C
cytosine
CAN
ceric ammonium nitrate
Cap
caproyl
Cas9
CRISPR associated protein 9
cat.
catalytic
or
catalyst
Cbz
benzyloxycarbonyl
CD
cluster of differentiation
CDI
1,1′-carbonyldiimidazole
CFL
compact fluorescent light
CIPE
complex-induced proximity effect
Cit
L
-citrulline
Cl
4
NHPI
tetrachloro-
N
-hydroxyphthalimide
CMD
concerted metalation–deprotonation
CNS
central nervous system
CoA
coenzyme A
cod
1,5-cyclooctadiene
coe
cyclooctene
Cp
cyclopentadienyl
CRISPR
clustered regularly interspaced short palindromic repeats
CSA
10-camphorsulfonic acid
CV
cyclic voltammetry
cy
or
Cy
cyclohexyl
Δ
heat
dab
2,9-bis(
p
-anisyl)-1,10-phenanthroline
DABCO
1,4-diazabicyclo[2.2.2]octane
DAST
(diethylamino)sulfur trifluoride
dba
(
E
,
E
)-dibenzylideneacetone
DBB
di-
tert
-butylbiphenylide
DBN
1,5-diazabicyclo[4.3.0]non-5-ene
DBU
1,8-diazabicyclo[5.4.0]undec-7-ene
DCC
1,3-dicyclohexylcarbodiimide
DDQ
2,3-dichloro-5,6-dicyano-1,4-benzoquinone
DDT
dichlorodiphenyltrichloroethane
DEAD
diethyl azodicarboxylate
DERA
2-deoxy-
D
-ribose-5-phosphate aldolase
dF(CF
3
)ppy
2-(2,4-difluorophenyl)-5-trifluoromethylpyridine
DG
directing group
DHPR
dihydropyridine receptor
DHQ
dihydroquinine
DIAD
diisopropyl azodicarboxylate
DIANANE
endo
,
endo
-2,5-diaminonorbornane
DIBAL-H
diisobutylaluminium hydride
dibm
diisobutyrylmethane
DMAP
4-dimethylaminopyridine
DMDO
3,3-dimethyldioxirane
DME
ethylene glycol dimethyl ether
DMF
N
,
N
-dimethylformamide
DMP
Dess–Martin periodinane
DMPU
1,3-dimethyl-3,4,5,6-tetrahydro-2(1
H
)-pyrimidinone
DMSO
dimethyl sulfoxide
DNA
deoxyribonucleic acid
DoM
directed
ortho
-metalation
DPBS
Dulbecco’s phosphate-buffered saline
dpm
dipivaloylmethanato
DPPA
diphenylphosphoryl azide
dppb
1,4-bis(diphenylphosphino)butane
dppf
diphenylphosphinoferrocene
dppp
1,3-bis(diphenylphosphino)propane
dr
diastereomeric ratio
dtbbpy
4,4′-di-
tert
-butyl-2,2′-bipyridine
DTBM
di-
tert
-butyl-4-methoxyphenyl
dtbpy
4,4′-di-
tert
-butyl-2,2′-bipyridine
EBX
ethynylbenziodoxolone
EC
50
half maximal effective concentration
ECC
excitation–contraction coupling
EDCI
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide
ee
enantiomeric excess
ep
error-prone
eq
equatorial
equiv
equivalent(s)
esp
α
,
α
,
α
′,
α
′-tetramethyl-1,3-benzenedipropionic acid
ETP
epipolythiodiketopiperazine
EWG
electron-withdrawing group
Fc
ferrocenyl
FDPP
furanyldiketopyrrolopyrrole
FMO
frontier molecular orbital
fod
1,1,1,2,2,3,3-heptafluoro-7,7-dimethyl-4,6-octanedionate
G
guanine
G2
gap 2
gen.
generation
Glc
glucose
GlyR
glycine receptors
GOase
galactose oxidase
HAT
hydrogen atom transfer
hfacac
hexafluoroacetylacetonate
HFIP
hexafluoroisopropanol
HIV
human immunodeficiency virus
HLF
Hofmann–Löffler–Freytag
HMDS
hexamethyldisilazane
HMG
3-hydroxy-3-methylglutaryl
HMPA
hexamethylphosphoramide
HOBt
1-hydroxybenzotriazole
HPLC
high-performance liquid chromatography
HRMS
high-resolution mass spectrometry
Hsp
heat shock protein
HWE
Horner–Wadsworth–Emmons
hν
light
IBX
o
-iodoxybenzoic acid
IC
50
50% inhibitory concentration
IC
70
70% inhibitory concentration
imid.
imidazole
Ipc
isopinocampheyl
i
-Pr
isopropyl
IR
infrared
ISC
intersystem crossing
k
reaction rate constant
KHMDS
potassium hexamethyldisilazide
LA
Lewis acid
LBA
Lewis acid-assisted chiral Brønsted acid
LD
50
50% lethal dose
LDA
lithium diisopropylamide
LED
light-emitting diode
LG
leaving group
LiHMDS
lithium hexamethyldisilazide
liq.
liquid
LLG-5
Linckia laevigata
ganglioside 5
LLS
longest linear sequence
LSF
late-stage functionalization
M
molar
M
mitosis
Mal
maleimido
MC
metal-centered
m
-CPBA
m
-chloroperoxybenzoic acid
MDR
multi-drug resistance
MeOH
methanol
MES
mesityl (2,4,6-trimethylphenyl)
MIC
minimum inhibitory concentration
MLCT
metal-to-ligand charge transfer
MMPP
magnesium monoperoxyphthalate hexahydrate
MMTrCl
4-methoxytriphenylmethyl
MNBA
2-methyl-6-nitrobenzoic anhydride
modp
bis(1-morpholinocarbamoyl-4,4-dimethyl-1,3-pentanedionato) [i.e., 4-[5,5-dimethyl-2,4-di(oxo-κ
O
)-1-oxohexyl]morpholinato]
mol.
molecular
MOM
methoxymethyl
MoOPH
oxodiperoxymolybdenum(pyridine)(hexamethylphosphoric triamide)
MPAA
mono-
N
-protected amino acid
MPO
4-methylpyridine
N
-oxide
Ms
methanesulfonyl
MS
molecular sieves
MVK
methyl vinyl ketone (butenone)
MW
microwave
N
normal (equivalent concentration)
NAD
+
nicotinamide adenine dinucleotide (oxidized form)
NADH
nicotinamide adenine dinucleotide (reduced form)
NADP
+
nicotinamide adenine dinucleotide phosphate (oxidized form)
NADPH
nicotinamide adenine dinucleotide phosphate (reduced form)
NaHMDS
sodium hexamethyldisilazide
Nap
naphthalenide
or
naphthalenyl
NBS
N
-bromosuccinimide
NCIMB
National Collection of Industrial, Food and Marine Bacteria
NCS
N
-chlorosuccinimide
Nf
nonafluorobutanesulfonyl
NHC
N
-heterocyclic carbene
NHK
Nozaki–Hiyama–Kishi
NIR
near-infrared
NIS
N
-iodosuccinimide
NMM
N
-methylmorpholine
NMO
4-methylmorpholine
N
-oxide
NMP
N
-methylpyrrolidone
NMR
nuclear magnetic resonance
NOE
nuclear Overhauser effect
Ns
nitrobenzenesulfonyl
Nu
nucleophile
ox
oxalate
PABC
p
-aminobenzyloxycarbonyl
PAF
platelet-activating factor
PAFR
platelet-activating factor receptor
PanK
pantothenate kinase
PBR
peripheral benzodiazepine receptor
Pc
phthalocyanine
PCC
pyridinium chlorochromate
PCR
polymerase chain reaction
PDC
pyridinium dichromate
PDP
2-({(
S
)-2-[(
S
)-1-(pyridin-2-ylmethyl)pyrrolidin-2-yl]pyrrolidin-1-yl}methyl)pyridine
PdPc
palladium(II) octabutoxyphthalocyanine
PET
positron emission tomography
or
photoinduced electron transfer
PG
protecting group
Ph
phenyl
phen
1,10-phenanthroline
PHOX
2-[2-(diphenylphosphino)phenyl]-2-oxazoline
pin
pinacolato
PIPES
piperazine-
N
,
N
′-bis(2-ethanesulfonic acid)
Piv
pivaloyl
PKC
protein kinase C
PKS
polyketide synthase
PMB
4-methoxybenzyl
PMP
4-methoxyphenyl
or
1,2,2,6,6-pentamethylpiperidine
PNP
p
-nitrophenol
or
purine nucleoside phosphorylase
PPM
phosphopentomutase
PPO
pyrophosphate
PPTS
pyridinium 4-toluenesulfonate
ppy
2-phenylpyridine
PS-BEMP
polystyrene-bound 2-
tert
-butylimino-2-diethylamino-1,3-dimethyl-perhydro-1,3,2-diazaphosphorine
py
pyridine
PyOX
2-(pyridin-2-yl)-4,5-dihydrooxazole
quant.
quantitative
RCM
ring-closing metathesis
Red-Al
sodium bis(2-methoxyethoxy)aluminium hydride
RHF
restricted Hartree–Fock model
RNA
ribonucleic acid
rsm
recovered starting material
RyR
ryanodine receptor
Sal
salen
SAR
structure–activity relationship
SCE
saturated calomel electrode
SET
single-electron transfer
Sia
siamyl
SP
sucrose phosphorylase
sp.
species
T
thymine
TAS-F
tris(dimethylamino)sulfonium difluorotrimethylsilicate
TBADT
tetra-
n
-butylammonium decatungstate
TBAF
tetra-
n
-butylammonium fluoride
TBAI
tetra-
n
-butylammonium iodide
TBD
triazabicyclodecene
TBDPS
tert
-butyldiphenylsilyl
TBDPSCl
tert
-butyldiphenylchlorosilane
TBHP
tert
-butyl hydroperoxide
TBOx
tethered bis(8-quinolinolato)
TBS
tert
-butyldimethylsilyl
TCAI
trichloroacetimidate
TCPTAD
adamantan-1-yl-(4,5,6,7-tetrachloro-1,3-dioxo-1,3-dihydroisoindol-2-yl)acetate
TDAE
tetrakis(dimethylamino)ethylene
TEMPO
2,2,6,6-tetramethyl-1-piperidinyloxy, free radical
Teoc
2-(trimethylsilyl)ethoxycarbonyl
TES
triethylsilyl
Tf
trifluoromethanesulfonyl
TFA
trifluoroacetic acid
TFAA
trifluoroacetic anhydride
tfb*
tetrafluorobenzobarrelene
TFMS
zinc trifluoromethanesulfinate
THF
tetrahydrofuran
THP
tetrahydropyranyl
TIPS
triisopropylsilyl
Tle
tert
-leucine
TMEDA
N
,
N
,
N
′,
N
′-tetramethylethylenediamine
TMP
2,2,6,6-tetramethylpiperidide
tmphen
3,4,7,8-tetramethyl-1,10-phenanthroline
TMS
trimethylsilyl
TMTU
tetramethylthiourea
tol
or
Tol
tolyl
TPAP
tetra-
n
-propylammonium perruthenate
TPCP
1,2,2-triphenylcyclopropanecarboxylate
TPP
tetraphenylporphyrin
Tris
2,4,6-triisopropylbenzenesulfonyl
Ts
4-toluenesulfonyl
TS
transition state
Txn
trioxacarcin
UHP
urea hydrogen peroxide complex
USSR
Union of Soviet Socialist Republics
UV
ultraviolet
vs.
versus